Clinical Trial Update: Registration of Idarucizumab for Patients with IntraCranial Hemorrhage

View source ↗

Summary

Registration and status update for idarucizumab (Praxbind) in patients with intracranial hemorrhage.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracranial Hemorrhage

Drugs mentioned

• Praxbind (Idarucizumab)

Snippet

Sponsor: University Hospital, Essen | Conditions: Intracranial Hemorrhage | Status: COMPLETED